ADVFN - Advanced Financial Network.
HOME» NYSE » C » CAH Stock Price » CAH Stock News

Cardinal Health Share News

 Cardinal Health, Inc. Stock Price
CAH Stock Price
 Cardinal Health, Inc. Stock Chart
CAH Stock Chart
 Cardinal Health, Inc. Stock News
CAH Stock News
 Cardinal Health, Inc. Company Information
CAH Company Information
 Cardinal Health, Inc. Stock Trades
CAH Stock Trades

WSJ BLOG/Health: A.M. Vitals: New Alzheimer's Trial; Home HIV Test

(This story has been posted on The Wall Street Journal Online's Health Blog at By Stefanie Ilgenfritz Here's what's making health news this morning: New Bid to Prevent Alzheimer's Early (WSJ): An Alzheimer's drug to be tested mostly on an extended family predisposed to the disease will mark the first large-scale trial of an experimental treatment on people who don't yet show signs of memory loss. Cardinal Health Settles With U.S. Over Pills (WSJ): The U.S. government on Tuesday settled with Cardinal Health over allegations the company distributed large quantities of addictive pain pills in Florida, backing away from a legal showdown over the pharmacy industry's responsibility for what officials call the country's deadliest drug problem. FDA Panel Backs HIV Home Test (WSJ): The mouth-swab test, made by OraSure Technologies, is sold commercially to health-care professionals to be used at facilities. If approved by the FDA, the test results could be obtained in the home like tests for pregnancy and blood sugar. Soda Makers Scramble to Fill Void as Sales Drop (NY Times): Cold, bubbly, sweet soda, long the American Champagne, is becoming product non grata in more places these days. Assisted Suicide, or Show of Love? (LA Times): With few precedents to guide them, prosecutors are left to wonder at what point assisting a suicide becomes a criminal act. Weight Loss Surgery Triggered Rare Genetic Wasting Disorder (USA Today): The death rate from the actual surgery is less than 1 percent, but complications can occur later, ranging from calcium malabsorption to the rare genetic disorder that killed a Tennessee woman. Drug Makers Continue Shift to Targeted Therapies (Dow Jones): The continuing shift away from one-size-fits-all cancer treatments will be on display this week when a medical society releases clinical data for drugs that target unique molecular features of cancer cells. -For continuously updated news from The Wall Street Journal, see at

Stock News for Cardinal Health (CAH)
10/18/201611:00:00Independent Community Pharmacies Vital to Patient Medication...
10/18/201608:39:20Statement of Changes in Beneficial Ownership (4)
10/05/201605:00:00Cardinal Health Expands in Asia
09/30/201609:00:00The Medical Device Industry's Focus on Cardio and Cardiovascular...
09/28/201608:30:00Cardinal Health to Webcast Discussion of First-Quarter Results...
09/19/201608:27:31Statement of Changes in Beneficial Ownership (4)
09/19/201608:27:03Statement of Changes in Beneficial Ownership (4)
09/19/201608:26:35Statement of Changes in Beneficial Ownership (4)
09/19/201608:26:03Statement of Changes in Beneficial Ownership (4)
09/16/201606:49:13Additional Proxy Soliciting Materials (definitive) (defa14a)
09/16/201606:45:58Proxy Statement (definitive) (def 14a)
09/06/201606:59:00Navidea Biopharmaceuticals Enters into Letter of Intent with...
08/31/201609:00:00Fighting Prescription Drug Misuse through Community Programs:...
08/22/201616:46:24Statement of Changes in Beneficial Ownership (4)
08/22/201616:45:56Statement of Changes in Beneficial Ownership (4)
08/17/201616:35:18Statement of Changes in Beneficial Ownership (4)
08/17/201616:34:52Statement of Changes in Beneficial Ownership (4)
08/17/201616:34:27Statement of Changes in Beneficial Ownership (4)
08/17/201616:34:01Statement of Changes in Beneficial Ownership (4)

Cardinal Health and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations